Glazar, D.J.; Grass, G.D.; Arrington, J.A.; Forsyth, P.A.; Raghunand, N.; Yu, H.-H.M.; Sahebjam, S.; Enderling, H.
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. J. Clin. Med. 2020, 9, 2019.
https://doi.org/10.3390/jcm9072019
AMA Style
Glazar DJ, Grass GD, Arrington JA, Forsyth PA, Raghunand N, Yu H-HM, Sahebjam S, Enderling H.
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. Journal of Clinical Medicine. 2020; 9(7):2019.
https://doi.org/10.3390/jcm9072019
Chicago/Turabian Style
Glazar, Daniel J., G. Daniel Grass, John A. Arrington, Peter A. Forsyth, Natarajan Raghunand, Hsiang-Hsuan Michael Yu, Solmaz Sahebjam, and Heiko Enderling.
2020. "Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma" Journal of Clinical Medicine 9, no. 7: 2019.
https://doi.org/10.3390/jcm9072019
APA Style
Glazar, D. J., Grass, G. D., Arrington, J. A., Forsyth, P. A., Raghunand, N., Yu, H.-H. M., Sahebjam, S., & Enderling, H.
(2020). Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. Journal of Clinical Medicine, 9(7), 2019.
https://doi.org/10.3390/jcm9072019